Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jul-Aug;3(4):187-92.
doi: 10.4161/trns.20711. Epub 2012 Jul 1.

Role of host cell factor-1 in cell cycle regulation

Affiliations
Review

Role of host cell factor-1 in cell cycle regulation

Zaffer Zargar et al. Transcription. 2012 Jul-Aug.

Abstract

Host cell factor-1(HCF-1) was first discovered as a cellular cofactor in the VP16-induced complex, a multi-protein DNA complex that forms on immediate early gene promoters of herpes simplex virus (HSV) to activate viral gene transcription. Subsequent research has revealed HCF-1 to be an abundant chromatin-associated protein that regulates various stages of the cell cycle. Recent reports show that HCF-1 interacts with diverse E2F proteins to induce cell-cycle-specific transcription. HCF-1 can act as a scaffold to a variety of histone-modifying proteins and these HCF-1-E2F-containing multi-protein complexes can bring about context-dependent activation or repression of transcription. In this review we examine the diversity of HCF-E2F interactions and the variety of multi-protein complexes it occurs in, to influence the local chromatin landscape at the E2F-promoters.

PubMed Disclaimer

Figures

None
Figure 1. Model for E2F-HCF-1 complexes during the cell cycle. This model illustrates the interactions of HCF-1 with various members of E2F family during the cell cycle and the different co-factors associated with them. (A) During early G1 phase, HCF-1 interacts with E2F4 and recruits Sin3 HDAC to E2F-responsive promoters. We speculate that this mechanism of repression is independent of pocket proteins. ANCCA binds to E2F-promoters in late mitosis. However, we do not know if HCF-1 and ANCCA co-occupy these promoters at this time. (B) This model proposes that HCF-1 forms an intermediate complex with pRB-E2F, where pRb has undergone phosphorylation by cyclin D /CDK4 but still remains bound to E2F. As the G1 to S phase transition progresses, this intermediate complex is freed of pRb by subsequent phosphorylation by cyclin/CDK complex thereby switching from repressive (pRb) to activating (HCF-1) E2F-complex., (C) Here we speculate the co-factors associated with E2F1 during S phase. ANCCA gets recruited to chromatin by binding to H3K14ac mark. Here it facilitates the loading of E2F to the chromatin. HCF-1 binds to E2F to promote the activation of S-phase genes by recruiting H3K4 HMT (MLL /Set1) and stimulating H3K4 trimethylation of gene promoters. PHF8 binds to H3K4 me2/3 mark and interacts with HCF-1. It removes the repressive H4K20 me1 marks at these promoters. Previous reports have shown that several histone acetyltransferase (HAT) are required for E2F activity.-

References

    1. Rodriguez-Jato S, Busturia A, Herr W. Drosophila melanogaster dHCF interacts with both PcG and TrxG epigenetic regulators. PLoS One. 2011;6:e27479. doi: 10.1371/journal.pone.0027479. - DOI - PMC - PubMed
    1. Rizki G, Iwata TN, Li J, Riedel CG, Picard CL, Jan M, et al. The evolutionarily conserved longevity determinants HCF-1 and SIR-2.1/SIRT1 collaborate to regulate DAF-16/FOXO. PLoS Genet. 2011;7:e1002235. doi: 10.1371/journal.pgen.1002235. - DOI - PMC - PubMed
    1. Tyagi S, Herr W. E2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferases. EMBO J. 2009;28:3185–95. doi: 10.1038/emboj.2009.258. - DOI - PMC - PubMed
    1. Dejosez M, Krumenacker JS, Zitur LJ, Passeri M, Chu LFF, Songyang Z, et al. Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells. Cell. 2008;133:1162–74. doi: 10.1016/j.cell.2008.05.047. - DOI - PMC - PubMed
    1. Glinsky GV, Berezovska O, Glinskii AB. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest. 2005;115:1503–21. doi: 10.1172/JCI23412. - DOI - PMC - PubMed

Publication types